UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The integrated landscape of driver genomic alterations in glioblastoma

Nature genetics, 2013-10, Vol.45 (10), p.1141-1149

2013

Volltextzugriff (PDF)

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Oncotarget, 2014-03, Vol.5 (6), p.1515-1525

2014

Volltextzugriff (PDF)

Integrated Genomic Analysis of Human Glioblastoma Multiforme

Science (American Association for the Advancement of Science), 2008-09, Vol.321 (5897), p.1807-1812

2008

Volltextzugriff (PDF)

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas

Nature communications, 2024-01, Vol.15 (1), p.730-18, Article 730

2024

Volltextzugriff (PDF)

Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

International journal of cancer, 2013-05, Vol.132 (10), p.2339-2348

2013

Volltextzugriff (PDF)

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Oncotarget, 2013-11, Vol.4 (11), p.2144-2153

2013

Volltextzugriff (PDF)

Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (9), p.1563-1575

2023

Volltextzugriff (PDF)

Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

Clinical cancer research, 2013-09, Vol.19 (17), p.4717-4727

2013

Volltextzugriff (PDF)

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Molecular carcinogenesis, 2007-06, Vol.46 (6), p.488-496

2007

Volltextzugriff (PDF)

A neural tract-inspired conduit for facile, on-demand biopsy of glioblastoma

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae064-vdae064

2024

Volltextzugriff (PDF)

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Cancers, 2023-09, Vol.15 (18), p.4619

2023

Volltextzugriff (PDF)

Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors

Anti-cancer agents in medicinal chemistry, 2011-02, Vol.11 (2), p.202-212

2011

Volltextzugriff (PDF)

Correction: Reversing the Warburg effect as a treatment for glioblastoma

The Journal of biological chemistry, 2018-09, Vol.293 (39), p.14973-14973

2018

Volltextzugriff (PDF)

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models

Journal of neuro-oncology, 2018-07, Vol.138 (3), p.489-498

2018

Volltextzugriff (PDF)

The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Cancer immunology research, 2024-06, Vol.12 (6), p.759-OF20

2024

Volltextzugriff (PDF)

Screening for distress in patients with brain cancer using the NCCN's rapid screening measure

Psycho-oncology (Chichester, England), 2008-06, Vol.17 (6), p.621-625

2008

Volltextzugriff (PDF)

Exomic sequencing of four rare central nervous system tumor types

Oncotarget, 2013-04, Vol.4 (4), p.572-583

2013

Volltextzugriff (PDF)

Levels of stress and intervention preferences of caregivers of brain tumor patients

Cancer nursing, 2007-11, Vol.30 (6), p.E33-E39

Keir, Stephen T

2007

Volltextzugriff (PDF)

Initial testing of topotecan by the pediatric preclinical testing program

Pediatric blood & cancer, 2010-05, Vol.54 (5), p.707-715

2010

Volltextzugriff (PDF)

Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer

Psycho-oncology (Chichester, England), 2007-03, Vol.16 (3), p.232-240

2007

Volltextzugriff (PDF)

Exercise interest and preferences among patients diagnosed with primary brain cancer

Supportive care in cancer, 2007-01, Vol.15 (1), p.47-55

2007

Volltextzugriff (PDF)

PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii38-iii38

2014

Volltextzugriff (PDF)

IDENTIFICATION AND PRELIMINARY TREATMENT DATA OF XENOGRAFTS REPRESENTING TCGA-DEFINED SUBTYPES

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii35-iii35

2014

Volltextzugriff (PDF)

The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion

Molecular cancer therapeutics, 2007-09, Vol.6 (9), p.2449-2457

2007

Volltextzugriff (PDF)

Stress and long-term survivors of brain cancer

Supportive care in cancer, 2007-12, Vol.15 (12), p.1423-1428

2007

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Chemotherapy And Pharmacology

ThemaAnimals

ThemaMice, Nude

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(157)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(184)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The integrated landscape of driver genomic alterations in glioblastoma

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Integrated Genomic Analysis of Human Glioblastoma Multiforme

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas

Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells

Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

A neural tract-inspired conduit for facile, on-demand biopsy of glioblastoma

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors

Correction: Reversing the Warburg effect as a treatment for glioblastoma

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models

The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Screening for distress in patients with brain cancer using the NCCN's rapid screening measure

Exomic sequencing of four rare central nervous system tumor types

Levels of stress and intervention preferences of caregivers of brain tumor patients

Initial testing of topotecan by the pediatric preclinical testing program

Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer

Exercise interest and preferences among patients diagnosed with primary brain cancer

PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT

IDENTIFICATION AND PRELIMINARY TREATMENT DATA OF XENOGRAFTS REPRESENTING TCGA-DEFINED SUBTYPES

The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion

Stress and long-term survivors of brain cancer

Aktive Filter

Suchergebnisse filtern